Pfizer and BioNtech have launched Covid-19 trials in children under 12
Pfizer and BioNTech have started covid-19 trials in children under 12, and are hoping for an expansion in covid vaccinations to that age by early 2022, the U.S drugmaker said on Thursday.
The first volunteers in the early-stage trial were given their first injections on Wednesday, Pfizer spokesperson Sharon Castillo said.
Pfizer and BioNTech vaccine was authorized by U.S regulators in late December for people above 16 years and above. According to the data from the U.S center for disease control and prevention, an account of 66 million doses of covid-19 vaccines have been administered in the united states on Wednesday morning March 24.
The pediatric trial of the vaccine which will include young children as 6 months old is similar to the one launched by Moderna last week.
...